Profusa, Inc. Common Stock
NASDAQ: PFSA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Ben Chung-Bin Hwang
- Employees
- 2
- Headquarters
- EmeryVille, United States
- IPO year
- 2025
- Market cap
- $72.4K
- Website
- https://profusa.com
Loading PFSA…
Loading profile data…Frequently asked questions about PFSA
What does Profusa, Inc. Common Stock (PFSA) do?
Profusa, Inc. is a pioneering health technology firm that engineers advanced, bio-integrated sensors. These innovative devices, exemplified by their Lumee™ Oxygen Platform, are designed for uninterrupted observation of internal physiological markers. By leveraging artificial intelligence, Profusa translates this constant stream of data into acti...
Where does PFSA trade?
Profusa, Inc. Common Stock (PFSA) trades on the NASDAQ Global Market.
What sector is PFSA in?
Profusa, Inc. Common Stock (PFSA) operates in the Healthcare sector, specifically in the Medical - Equipment & Services industry.
Who is the CEO of Profusa, Inc. Common Stock?
Ben Chung-Bin Hwang is the chief executive officer of Profusa, Inc. Common Stock (PFSA).
Where is Profusa, Inc. Common Stock headquartered?
Profusa, Inc. Common Stock is headquartered in United States.
Does PFSA pay a dividend?
Profusa, Inc. Common Stock (PFSA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PFSA go public?
Profusa, Inc. Common Stock (PFSA) completed its initial public offering in 2025.